The pathophysiology of neuropsychiatric disorders, including depression, is linked to a disrupted serine/threonine kinase glycogen synthase kinase 3β (Akt/GSK3β signaling pathway) [18,19]. The gene discussed is GSK3B; the disease is depressive disorder.